MedPath

Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound

Phase 4
Completed
Conditions
Aortic Valve Stenosis
Extracorporeal Circulation
Interventions
Procedure: Conventional Extracorporeal Circulation (CECC)
Procedure: Minimized Extracorporeal Circulation (MECC)
Registration Number
NCT02308566
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

In this study, the investigators aim to compare cerebral embolic load in patients undergoing surgical aortic valve replacement using either the minimized extracorporeal circulation or the conventional extracorporeal circulation technique. The detection of cerebral emboli is performed not-invasively by transcranial Doppler detection of high-intensity transient signals representing solid or gaseous microembolism in the middle cerebral arteries. The investigators hope to get more insight in the mechanism (incl. quantity) of cerebral embolism during aortic valve surgery using extracorporeal circulation.

Detailed Description

Background

The gold standard to treat severe aortic valve stenosis is currently the surgical aortic valve replacement (SAVR) using conventional extracorporeal circulation (CECC). SAVR, however, can be performed also on minimized extracorporeal circulation (MECC), which is characterized by reduced priming volume and interfaces between blood and artificial surfaces and blood-air interface, respectively. Further technical developments of the MECC system together with reports on less induction of the coagulation cascade and activation of inflammatory systemic response may account for a reduced incidence of microbubble generation with MECC system.

Objective

The aim of the is to investigate the procedural-related incidence of high-intensity transient signals (HITS) representing solid or gaseous microembolism reaching the cerebral vessels.

Methods

Patients undergoing SAVR are included in the study and randomised to either MECC or CECC technique. HITS are continuously bilaterally detected during the entire intraoperative period by transcranial Doppler ultrasound.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Isolated Severe Aortic Valve Stenosis
  • No other cardiac disease
  • No other coronary heart disease
  • Written informed consent

Exclusion Criteria

  • Double valve surgery
  • Concomitant coronary artery bypass surgery
  • Vascular surgery
  • Age < 18 yrs.
  • Age > 80 yrs.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional Extracorporeal Circulation TechniqueConventional Extracorporeal Circulation (CECC)Conventional Extracorporeal Circulation Technique
Minimized Extracorporeal Circulation TechniqueMinimized Extracorporeal Circulation (MECC)Minimized Extracorporeal Circulation Technique
Primary Outcome Measures
NameTimeMethod
Total and interval-related cerebral microembolic load as measured by transcranial DopplerIntraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)
Secondary Outcome Measures
NameTimeMethod
Cerebral complications, e.g. delirium and stroke as detected clinicallyIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Redo surgeryIn-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital MortalityIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Extubation timeIn-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital infectionsIn-hospital period (until hospital discharge, duration approx. 7-10 days)
ICU length of stayIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Thromboembolic complicationsIn-hospital period (until hospital discharge, duration approx. 7-10 days)

Trial Locations

Locations (1)

University Hospital Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath